|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | PTEN expres- sion controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells显示文摘 | Bouali S Chretien A S Ramacci C etal | 2009 | OncolRep2009，21，3： | 1 |
| 2 | PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type,hormone refractory prostate cancer cells显示文摘 | BOUALI S CHR(E)TIEN A S RAMACCI C | 2009 | Oncol Rep2009，21，3： | 1 |
| 3 | PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type,hormone refractory prostate cancer cells显示文摘 | BOUALI S CHR(E)TIEN AS RAMACCI C | | 0，，03： | 1 |
| 4 | PTEN expression controls cellular response to cetuximab by mediating PBK/AKT and RAS/RAF/MAPK downstream signaling in KRAS wildtype, hormone refractory prostate cancer cells 显示文摘 | Bouali S Chr6tien AS Ramacci C | 2009 | Oncol Rep2009，21，3： | 1 |
| 5 | PTEN expression controis cellular response to cetuxinmb by mediating PD K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type,hormone refractory prostate cancer cells 显示文摘 | Bouali S Chrtien AS Ramacci C | 2009 | Oncology Reports2009，21，3： | 1 |
| 6 | PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF! MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells 显示文摘 | BOUALI S CHRETIEN A S RAMACCI C | 2009 | Onol Rep2009，21，3： | 1 |
| 7 | PTEN expression controis cellular response to cetuximab by mediating PDK/AKTand RAS/RAF/MAPK downstream signaling in KRAS wild-type,hormone refractory prostate cancer cells显示文摘 | Bouali S Chretien A S Ramacci C | 2009 | Oncol Rep2009，21，3： | 1 |
| 8 | PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells 显示文摘 | Bouali S Chretien AS Ramacci C | 2009 | Oncol Rep2009，21，3： | 1 |
| 9 | p53 and PTEN expressioncontribute to the inhibition if EGFR downstream signaling pathwangby ceteximab显示文摘 | Bouali S Chretien AS Ramacci C | 2009 | Cancer Gene Ther2009，16，6： | 1 |
| 10 | P53 and PTEN expression contribute to the inhibition of EGFR downstream signaling pathway by cetuximab显示文摘 | Bouali S Chr é tien AS Ramacci C | | 0，，06： | 1 |
| 11 | PTEN expression con- trois cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hor- mone refractory prostate cancer ceils 显示文摘 | Bouali S Chretien AS Ramacci C | 2009 | Oncol Rep2009，21，3： | 1 |
| 12 | PTEN expression con- tmls cellular response to cetuximab by mediating P13K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hor- mone fractory prostate cancer cells 显示文摘 | Bouali S Chr6tien AS Ramacci C | 2009 | Oncol Rep2009，21，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员